What is Simcere Pharmaceutical Group Price-to-Operating-Cash-Flow?
As of today (2024-06-19), Simcere Pharmaceutical Group's share price is HK$5.78.
Simcere Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.06. Hence, Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow Ratio for today is 90.31.
The historical rank and industry rank for Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow or its related term are showing as below:
HKSE:02096'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.59 Med: 84.69 Max: 315
Current: 90.47
During the past 7 years, Simcere Pharmaceutical Group's highest Price-to-Operating-Cash-Flow Ratio was 315.00. The lowest was 10.59. And the median was 84.69.
Simcere Pharmaceutical Group's Cash Flow from Operations per share for the
six
months ended in Dec. 2023 was HK$0.10.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.06.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Simcere Pharmaceutical Group was -89.10% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 12.70% per year.
During the past 7 years, Simcere Pharmaceutical Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 20.50% per year. The lowest was -53.10% per year. And the median was 12.70% per year.
Simcere Pharmaceutical Group Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simcere Pharmaceutical Group Price-to-Operating-Cash-Flow Chart
|
Simcere Pharmaceutical Group Annual Data
|
|
Trend |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
204.55 |
- |
20.14 |
106.83 |
|
Simcere Pharmaceutical Group Semi-Annual Data
|
|
Dec17 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
- |
- |
20.14 |
- |
106.83 |
Competitive Comparison of Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow falls into.
Simcere Pharmaceutical Group Price-to-Operating-Cash-Flow Calculation
Simcere Pharmaceutical Group's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 5.78 | / | 0.064 |
| = | 90.31 |
Simcere Pharmaceutical Group's Share Price of today is HK$5.78.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Simcere Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Simcere Pharmaceutical Group (HKSE:02096) Business Description
Traded in Other Exchanges
Address
No. 699-18, Xuanwu Road, Xuanwu District, Jiangsu, Nanjing, CHN, 210042
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.
Executives
Simcere Pharmaceutical Group (HKSE:02096) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02096 has been successfully added to your